CS logo
small CS logo
Institut Jules Bordet-Hopital Universitaire ULB

Brussels, Belgium
Hospital in Anderlecht
Rue Meylemeersch 90, 1070 Bruxelles

About Institut Jules Bordet-Hopital Universitaire ULB


Institut Jules Bordet is a specialized general hospital and research institute of the Université libre de Bruxelles which specializes in oncology. It is located in Brussels, Belgium.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
European Organisation for Research and Treatment of Cancer - EORTC
4
Total Rows: 1

Clinical Trials at Institut Jules Bordet-Hopital Universitaire ULB


During the past decade, Institut Jules Bordet-Hopital Universitaire ULB conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100112200000000Started TrialsCompleted Trails20172018201920200123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal Carcinoma
2017-11-27
2029-09-01
Recruiting
112
Adjuvant Palbociclib in Elderly Patients With Breast Cancer
2019-06-14
2032-09-30
Active, not recruiting
366
Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients
2020-11-17
2024-07-01
Recruiting
100
Dissecting the Pathways of Therapy Resistance in Early Breast Cancer
2020-07-08
2023-07-31
Recruiting
100

Rows per page:

1–4 of 4

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Jules Bordet-Hopital Universitaire ULB" #1 collaborator was "Breast International Group" with 1 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator, "German Adjuvant Breast Cancer Group" with 1 trials as a collaborator, "Gruppo Oncologico Italiano di Ricerca Clinica" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.
Created with Highcharts 11.1.0Top Leading SponsorsEuropean Organisationfor Research andTreatment of Cancer -EORTC: 4European Organisationfor Research andTreatment of Cancer -EORTC: 4

Created with Highcharts 11.1.0Top CollaboratorsBreast International Group: 1Breast International Group: 1ETOP IBCSG PartnersFoundation: 1ETOP IBCSG PartnersFoundation: 1German AdjuvantBreast Cancer Group: 1German AdjuvantBreast Cancer Group: 1Gruppo OncologicoItaliano di RicercaClinica: 1Gruppo OncologicoItaliano di RicercaClinica: 1Pfizer: 1Pfizer: 1SOLTI Breast CancerResearch Group: 1SOLTI Breast CancerResearch Group: 1Swedish Association ofBreast Oncologists: 1Swedish Association ofBreast Oncologists: 1UNICANCER: 1UNICANCER: 1

Clinical Trials Conditions at Institut Jules Bordet-Hopital Universitaire ULB


According to Clinical.Site data, the most researched conditions in "Institut Jules Bordet-Hopital Universitaire ULB" are "Breast Cancer" (1 trials), "Breast Cancer Stage II" (1 trials), "Breast Cancer Stage III" (1 trials), "Hypopharyngeal Squamous Cell Carcinoma" (1 trials) and "Non Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Institut Jules Bordet-Hopital Universitaire ULB" in a lesser frequency.

Clinical Trials Intervention Types at Institut Jules Bordet-Hopital Universitaire ULB


Most popular intervention types in "Institut Jules Bordet-Hopital Universitaire ULB" are "Drug" (2 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Docetaxel / cyclophosphamide" (1 trials), "Intensity-Modulated Radiation Therapy (IMRT)" (1 trials), "Lorlatinib" (1 trials), "Palbociclib" (1 trials) and "Trans Oral Surgery (TOS)" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Institut Jules Bordet-Hopital Universitaire ULB


The vast majority of trials in "Institut Jules Bordet-Hopital Universitaire ULB" are 3 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Institut Jules Bordet-Hopital Universitaire ULB


Currently, there are NaN active trials in "Institut Jules Bordet-Hopital Universitaire ULB". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Institut Jules Bordet-Hopital Universitaire ULB, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Institut Jules Bordet-Hopital Universitaire ULB, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 2Phase 2: 2Not Applicable: 1Not Applicable: 1

Created with Highcharts 11.1.0Trials StatusRecruiting: 3Recruiting: 3Active, not recruiting: 1Active, not recruiting: 1